WAYNE, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: ACRS) (the “Company” or “Aclaris”), a clinical-stage ...

Qualigen Therapeutics (QLGN) has entered into definitive securities purchase agreements with several institutional and accredited investors ...

(NASDAQ: OMCL) (“Omnicell”) today announced that it intends to offer, subject to market conditions and other factors, $150.0 ...

Goldgroup Mining (TSE:GGA) has released an update.Don't Miss our Black Friday Offers:Discover the latest stocks recommended by top Wall Street ...

The flow-through component of the Private Placement will consist of up to 10.7 million FT Shares at a price of $0.14 cents per FT Share, for aggregate gross proceeds of up to $1,500,000 (the " FT ...

Aclaris Therapeutics ($ACRS) stock rose more than 46% on Tuesday after the clinical-stage biopharmaceutical company entered ...

The Quarterly Repayment will be made on 13 December 2024 and will be settled in its entirety in cash through the proceeds from Private Placement. Accordingly, the result of the Private Placement and ...

UK: Leasing company Porterbrook has closed a £250m private placement which includes existing and new investors, extending its ...

November 12, 2024) - Canadian Copper Inc. (CSE: CCI) ("Canadian Copper" or the " Company ") announces that it has initiated a ...

In response, the MCA conducted a hearing and issued a penalty order for non-compliance. The company and its directors were ...

The Common Shares issued pursuant to the Private Placement will be subject to a statutory hold period lasting four (4) months and one (1) day following the closing date. The Common Shares issued ...

The Company is initiating a non-brokered $300,000 private placement offering (the "Offering") of 15,000,000 units of the Company (each, a "Unit") at a price of $0.02 per Unit, each Unit being ...